One customer — 93% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, 93% of premiums were earned directly from CMS and 7% were from our members.”
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Oscar Health raised full-year 2026 earnings from operations guidance for a third time to $850 million to $950 million. Third-quarter revenue reached $5.1 billion, adjusted EBITDA was $207 million, and membership was approximately 2.7 million.
Oscar Health, Inc. reported total revenue of 14,666,712 and net income of 1,208,085 for nine months ended September 30, 2026, versus a 2025 net loss of 90,540, in thousands.
Oscar Health reported third-quarter total revenue of approximately $5.1 billion and net income attributable of $167.3 million, raising full-year earnings from operations guidance to between $850 million and $950 million.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| SG&A expense ratio | 14.2% | Three Months Ended June 30, 2026 filing | — |
| Adjusted EBITDA non-GAAP | 1.14B | Six Months Ended June 30 | — |
| Individual and Small Group | 2,963,002 | As of June 30, 2026 | — |
| Medical Loss Ratio | 75% | Six Months Ended June 30 | — |
| Total Members | 2,963,002 | As of June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OSCR
this stock
Oscar Health, Inc.
|
$9.65B | +116.1% | +27.5% | 12.6 | 5.4% |
|
UNH
Unitedhealth Group Inc
|
$365.09B | +23.4% | +11.8% | 23.3 | 1.6% |
|
CVS
CVS HEALTH Corp
|
$114.32B | +12.6% | +7.8% | 10.4 | 1.4% |
|
ELV
Elevance Health, Inc.
|
$92.84B | +22.6% | +12.5% | 18.3 | 2.1% |
|
CI
Cigna Group
|
$78.26B | +7.9% | +11.2% | 13.1 | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Oscar Health reported third-quarter total revenue of approximately $5.1 billion and net income attributable of $167.3 million, raising full-year earnings from operations guidance to between $850 million and $950 million.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OSCR | +1.3% | -2.6% | +41.9% | +2.2% | +116.1% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -1.3% | -1.5% | +41.4% | +2.4% | +105.5% |
